Table 1.
Clinical details of patients with ovarian metastases (n = 70)
| Factor | Number (%) |
|---|---|
| Performance status (ECOG) | |
| 0 | 4 (8.9) |
| 1 | 26 (57.8) |
| 2 | 8 (17.8) |
| 3 |
7 (15.6) Missing (25) |
| Clinical presentation | |
| Directly to the gynecologic oncology clinic | 43 (61.4) |
| Referred from another department | 27 (38.6) |
| Diagnosis | |
| Carcinoma stomach | 16 (22.9) |
| Unknown primary | 11 (15.7) |
| Carcinoma gall bladder | 9 (12.9) |
| Carcinoma colon | 9 (12.9) |
| Carcinoma breast | 6 (8.6) |
| Carcinoma appendix | 4 (5.7) |
| Lower GIT unspecified | 4 (5.7) |
| Carcinoma rectum | 4 (5.7) |
| Carcinoma lung | 3 (4.3) |
| Carcinoma pancreas | 1 (1.4) |
| Cholangiocarcinoma | 1 (1.4) |
| Histology | |
| Adenocarcinoma | 35 (50.7) |
| Adenocarcinoma with signet ring cells | 20 (28.6) |
| Carcinoma of mammary origin | 6 (8.6) |
| GIST | 2 (2.9) |
| Adenocarcinoma with extracellular mucin | 3 (4.3) |
| Clear cell carcinoma | 1 (1.4) |
| Imaging | |
| Peritoneal carcinomatosis | 54 (76.8) |
| Isolated ovarian metastasis | 16 (23.2) |
| Interventions | |
| Laparoscopy and biopsy | 1 (1.4) |
| Laparoscopy and oophorectomy | 2 (2.9) |
| Laparotomy and cytoreduction | 12 (17.1) |
| Image-guided biopsy | 33 (47.1) |
| Gastrointestinal endoscopy and biopsy | 16 (22.9) |
| Endometrial biopsy | 1 (1.4) |
| Indication for surgery (n = 18) |
Diagnostic—2 (11%) Symptomatic—1 (5.6%) Ovarian function suppression for carcinoma breast—3 (16.7%) Suspected primary ovarian cancer—11 (61.1%) Metastasectomy—1 (5.6%) |